Manhattan Scientifics Reaches the Fork (Falk) in the Road
AstraZeneca Sees Positive Results From CAZ-AVI Antibiotic Trial
Trevena Granted Key U.S. Method of Use Patent for TRV027
While more than one third of these top fund managers are outperforming this year, four of them stand out from the rest given their ability to outperform the market over almost all time periods.
As credit spreads have tightened on a nearly continuous trend over the past year, they are becoming richly valued relative to their historical average.
Increased investor inflows and portfolio reshuffling (driven in part by a fairly valued market), has added breadth to the high-conviction and new-money purchases we've seen so far from our top managers.
Some great funds see attractive opportunities in the health-care sector.